Overview

89Zr-labeled NY008 PET Imaging in Patients

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY008 PET Imaging in patients with multiple myeloma
Phase:
Early Phase 1
Details
Lead Sponsor:
Affiliated Hospital of Jiangnan University